Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors
Resistance to therapy in patients with solid cancers represents a daunting challenge that must be addressed. Indeed, current strategies are still not effective in the majority of patients; which has resulted in the need for novel therapeutic approaches. Cancer stem cells (CSCs), a subset of tumor ce...
Main Authors: | Maria Serena Roca, Elena Di Gennaro, Alfredo Budillon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/7/912 |
Similar Items
-
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
by: Christian Mayr, et al.
Published: (2021-07-01) -
The efficacy of HDAC inhibitors in neoplasm treatment
by: Dominika Psiuk, et al.
Published: (2020-08-01) -
Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
by: Nakashima H, et al.
Published: (2015-11-01) -
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
by: Somy Yoon, et al.
Published: (2019-03-01) -
Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
by: Simone Moertl, et al.
Published: (2019-07-01)